Actinium Pharmaceuticals reported $0 in Sales Revenues for its fiscal quarter ending in March of 2025.





Sales Change Date
AbbVie USD 16.62B 840M Dec/2025
Actinium Pharmaceuticals USD 0 0 Mar/2025
Amgen USD 9.9B 340M Dec/2025
Bioline Rx USD 427K 123K Sep/2025
Capricor Therapeutics USD 0 11.13M Mar/2025
Pfizer USD 17.58B 880M Dec/2025